BioSpace News Archive

Panbela Therapeutics, Inc., a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, announced that it will implement the previously announced and stockholder approved 1-for-30 reverse split of its common stock.

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today announced positive feedback from the FDA on the Company’s proposed single confirmatory Phase 3 study of investigational monoclonal antibody candidate AR-301.

Lynk Pharmaceuticals Co., Ltd. today announced the successful completion of a RMB 200 million Series C1 financing round.

Mileutis announced that David Javier Iscovich, CEO and co-founder, will be presenting at the Stifel 2023 Jaws & Paws Conference in New York City, May 31st, 2023.

IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) developer of the ProSense® System, today announced that ProSense was recently installed and inaugurated at Kovai Medical Center and Hospital (“KMCH”) in Coimbatore, India.

Tavanta Therapeutics today announced that it will present new data from its metastatic prostate cancer program during the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting taking place June 2-6 in Chicago, as well as from its anal fissure program during the upcoming American Society of Colon and Rectal Surgeons (ASCRS) Annual Meeting being held June 3-6 in Seattle.

Abcuro, Inc. today announced completion of enrollment of the sentinel cohort of a Phase 2/3 study of ABC008 for the treatment of inclusion body myositis (IBM).

IconOVir Bio, Inc. today announced that Mark McCamish, M.D., Ph.D., President and Chief Executive Officer of IconOVir, will present a corporate overview at the Jefferies Healthcare Conference on Wednesday, June 7, 2023 at 4:30 p.m. ET (1:30 p.m. PT).

DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced that the DermTech Melanoma Test has tested more than 200,000 suspicious pigmented lesions.

Astria Therapeutics, Inc. today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will participate in a fireside chat at the upcoming Jefferies Healthcare Conference on Wednesday, June 7th at 2:00pm ET in New York, NY.